NAC Dosing (as Glutathione Precursor) General antioxidant support: 600-1,200 mg/day in divided doses [9][18] Respiratory conditions (COPD): 600-1,200 mg/day (PANTHEON trial used 600 mg twice daily) [43][44] Psychiatric conditions: 1,200-2,400 mg/day (most trials used 2,000-2,400 mg/day) [72][73][74] Male fertility: 600 mg/day [69] Immune support in elderly: 600-1,200 mg/day [40] GlyNAC Dosing The Kumar et al
Medication Adherence While medication adherence factors into outcomes associated with most all drugs, it is especially important with GLP1 receptor agonists, as significant weight gain frequently occurs after discontinuation of the drug
[9] It achieved commercial success with major depressive disorder drugs Prozac (fluoxetine) (1986), Cymbalta (duloxetine) (2004), and its antipsychotic medication Zyprexa (olanzapine) (1996), all of which are now off patent and are manufactured by others as generic drugs
To prevent long-term microvascular and macrovascular complications associated with hyperglycaemia, achieving and maintaining glycaemic control remains the primary goal of type 2 diabetes treatment
